The Safety and Efficacy of Ticagrelor for Coronary Stenting Post Thrombolysis (SETFAST) Trial
Phase of Trial: Phase III
Latest Information Update: 01 Feb 2018
Price : $35 *
At a glance
- Drugs Ticagrelor (Primary) ; Clopidogrel
- Indications Thrombosis
- Focus Therapeutic Use
- Acronyms SETFAST
- 21 Nov 2016 Status changed from recruiting to completed.
- 08 Dec 2015 Planned end date changed from 1 Dec 2015 to 1 Dec 2016, as reported by ClinicalTrials.gov.
- 08 Dec 2015 Planned primary completion date changed from 1 Dec 2015 to 1 Jul 2016, as reported by ClinicalTrials.gov.